NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

logo (PRNewsfoto/Halper Sadeh LLP)

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Supernus Pharmaceuticals, Inc. for $8.10 per share in cash plus two non-tradable contingent value rights collectively worth up to $1.00 per share in cash. If you are an Adamas shareholder, click here to learn more about your rights and options.  

Flexion Therapeutics, Inc. (NASDAQ: FLXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pacira BioSciences, Inc. for $8.50 per share in cash plus one non-tradeable contingent value right worth up to $8.00 per share in cash. If you are a Flexion shareholder, click here to learn more about your rights and options.

Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to SouthState Corporation. Subject to the terms of the merger agreement, Atlantic Capital shareholders will receive 0.36 shares of SouthState common stock for each outstanding share of Atlantic Capital common stock. If you are an Atlantic Capital shareholder, click here to learn more about your rights and options.

Square, Inc. (NYSE: SQ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Afterpay Limited. Afterpay shareholders are expected to receive Square common stock in connection with the merger. Following completion of the transaction, Square shareholders are expected to own approximately 81.5% of the combined company on a fully diluted basis. If you are a Square shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-adms-flxn-acbi-sq-shareholders-are-encouraged-to-contact-the-firm-301401301.html

SOURCE Halper Sadeh LLP